The effect of heparin administration time on thrombolysis in myocardial infarction flow grade in patients with acute ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Aboozar Fakhr-Mousavi, Shaghayegh Cheshmkhorooshan, Azin Vakilpour, Seyed Mehdi Mousavi
{"title":"The effect of heparin administration time on thrombolysis in myocardial infarction flow grade in patients with acute ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.","authors":"Aboozar Fakhr-Mousavi, Shaghayegh Cheshmkhorooshan, Azin Vakilpour, Seyed Mehdi Mousavi","doi":"10.48305/arya.v18i0.2681","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In the clinical setting of patients with ST-elevation myocardial infarction (STEMI), there are controversies about the role of early heparin administration on the patients' outcome and the patency of the infarct-related artery (IRA). In this randomized clinical trial, we sought to investigate the effect of heparin administration time on the thrombolysis in myocardial infarction (TIMI) flow grade of patients with STEMI treated with primary percutaneous coronary intervention (PPCI).</p><p><strong>Methods: </strong>Eligible individuals were randomly assigned to two groups: early heparin administration (90 IU/kg) in the emergency department (group A, n = 92) and late heparin administration in the Cath lab (group B, n = 77). All demographic and clinical information and on admission examinations were documented. Clinical outcomes, 40-day mortality, and left ventricular (LV) function improvement in follow-up were also collected.</p><p><strong>Results: </strong>The mean age of patients was 57.1 ± 8.8 and 57.5 ± 7.5 years in groups A and B, respectively (P = 0.232). The history of hypertension (HTN) (34.8% vs. 53.2%, P = 0.016) and diabetes (14.1% vs. 29.9%, P = 0.013) was significantly lower in group A. The LV ejection fraction (LVEF) changes were significant before and after the intervention within each group. However, this change was not significantly different between the groups (P = 0.592). Post-intervention complications did not differ between the two groups (P > 0.05). In the proportion of cases with TIMI flow grade less than 2 in the IRA, no significant differences were observed between the groups. [P = 0.092 for left anterior descending (LAD) and P = 0.086 for left circumflex artery (LCX)].</p><p><strong>Conclusion: </strong>Although heparin administration in patients with STEMI undergoing PPCI is safe and effective, the effect appears not to be time-dependent.</p>","PeriodicalId":46477,"journal":{"name":"ARYA Atherosclerosis","volume":"18 3","pages":"1-7"},"PeriodicalIF":0.5000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3d/d8/ARYA-18-1-2681.PMC9931947.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ARYA Atherosclerosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.48305/arya.v18i0.2681","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: In the clinical setting of patients with ST-elevation myocardial infarction (STEMI), there are controversies about the role of early heparin administration on the patients' outcome and the patency of the infarct-related artery (IRA). In this randomized clinical trial, we sought to investigate the effect of heparin administration time on the thrombolysis in myocardial infarction (TIMI) flow grade of patients with STEMI treated with primary percutaneous coronary intervention (PPCI).
Methods: Eligible individuals were randomly assigned to two groups: early heparin administration (90 IU/kg) in the emergency department (group A, n = 92) and late heparin administration in the Cath lab (group B, n = 77). All demographic and clinical information and on admission examinations were documented. Clinical outcomes, 40-day mortality, and left ventricular (LV) function improvement in follow-up were also collected.
Results: The mean age of patients was 57.1 ± 8.8 and 57.5 ± 7.5 years in groups A and B, respectively (P = 0.232). The history of hypertension (HTN) (34.8% vs. 53.2%, P = 0.016) and diabetes (14.1% vs. 29.9%, P = 0.013) was significantly lower in group A. The LV ejection fraction (LVEF) changes were significant before and after the intervention within each group. However, this change was not significantly different between the groups (P = 0.592). Post-intervention complications did not differ between the two groups (P > 0.05). In the proportion of cases with TIMI flow grade less than 2 in the IRA, no significant differences were observed between the groups. [P = 0.092 for left anterior descending (LAD) and P = 0.086 for left circumflex artery (LCX)].
Conclusion: Although heparin administration in patients with STEMI undergoing PPCI is safe and effective, the effect appears not to be time-dependent.
背景:在st段抬高型心肌梗死(STEMI)患者的临床环境中,早期给药肝素对患者预后和梗死相关动脉(IRA)通畅的影响存在争议。在这项随机临床试验中,我们试图研究肝素给药时间对STEMI患者经原发性经皮冠状动脉介入治疗(PPCI)的心肌梗死溶栓(TIMI)血流等级的影响。方法:将符合条件的患者随机分为两组:急诊早期给予肝素(90 IU/kg)组(A组,n = 92)和Cath实验室晚期给予肝素组(B组,n = 77)。所有的人口统计和临床信息以及入院检查都被记录下来。还收集了临床结果、40天死亡率和随访中左心室功能的改善情况。结果:A组和B组患者平均年龄分别为57.1±8.8岁和57.5±7.5岁(P = 0.232)。a组高血压病史(HTN) (34.8% vs. 53.2%, P = 0.016)、糖尿病病史(14.1% vs. 29.9%, P = 0.013)均显著降低。各组干预前后左室射血分数(LVEF)变化均显著。但两组间差异无统计学意义(P = 0.592)。两组干预后并发症无显著性差异(P > 0.05)。在IRA中TIMI血流等级小于2的病例比例方面,两组间无显著差异。[左前降支(LAD) P = 0.092,左旋动脉(LCX) P = 0.086]。结论:虽然肝素在STEMI患者行PPCI是安全有效的,但其效果似乎不具有时间依赖性。